Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SYF

Synchrony Financial Loan Book Grows, Credit Performance Improves

Synchrony Financial’s loan book edged higher in July while credit performance improved modestly from June.

Period-end loan receivables rose to $102.6 billion at July 31, 2026, up from $102.2 billion at June 30 and $100.3 billion a year earlier. Average loan receivables increased to $101.9 billion from $101.3 billion in June and $99.7 billion in July 2025.

The 30-plus-day delinquency rate held at 4.2% in July, unchanged from June and down from 4.5% in July 2025. Delinquencies had peaked at 4.7% in February before easing to 4.2% in May, June and July.

Net charge-offs improved to 4.7% in July from 5.3% in June and 5.1% in July 2025. The rate had been 5.8% in February and March, then fell to 4.7% in January before moving back up in the spring.

After the recovery adjustment, the adjusted net charge-off rate was 4.9% in July, down from 5.2% in June and 5.1% a year earlier. That figure had been 5.8% in February and March, 5.6% in April, and 5.4% in May.

The month also showed a smaller gap between delinquencies and charge-offs than earlier in the year: July’s 4.2% delinquency rate versus a 4.7% net charge-off rate, compared with February’s 4.7% delinquency rate and 5.8% net charge-off rate. Following these announcements, the company's shares moved -0.56%, and are now trading at a price of $80.545. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS